SEC Form 4 · accession 0000899243-16-020667
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steinar J Engelsen
Director
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 6:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2016 | P | 9,671 | $1.21 | A | 13,610 | D | |
| Common Stock | May 20, 2016 | P | 9,150 | $1.25 | A | 22,760 | D |
Table II — derivative securities
No Table II lines on this filing.